Therapy of Autoimmune Liver Disease

The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible. Therefore, autoimmune liver diseases are presently treated by suppression of the immune response. Autoimmune hepatitis is characteristically responsive to corticosteroids, often used in combination with azathioprine to obtain a steroid-sparing effect. For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment. 

  • Autoimmune cholangitis
  • Autoimmune liver Disease
  • Liver Transplantation

Related Conference of Therapy of Autoimmune Liver Disease

July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
July 29-30, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
November 12-13, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
November 14-15, 2019

International Conference on Vaccines and Immune Response

Istanbul, Turkey
November 14-15, 2019

Annual Congress on Antibiotics and Antimicrobial Resistance

Geneva, Switzerland
November 21-22, 2019

World Conference on Vaccine and Immunology

Dubai, UAE

Therapy of Autoimmune Liver Disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in